10.53
price down icon0.47%   -0.05
after-market 시간 외 거래: 10.53
loading
전일 마감가:
$10.58
열려 있는:
$10.6
하루 거래량:
87,198
Relative Volume:
1.29
시가총액:
$165.64M
수익:
$166.88M
순이익/손실:
$-74.18M
주가수익비율:
-2.0769
EPS:
-5.07
순현금흐름:
$1.14M
1주 성능:
-6.23%
1개월 성능:
-5.56%
6개월 성능:
-36.03%
1년 성능:
-59.26%
1일 변동 폭
Value
$10.50
$10.98
1주일 범위
Value
$10.49
$11.38
52주 변동 폭
Value
$10.47
$29.11

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
명칭
Anika Therapeutics Inc
Name
전화
(781) 457-9000
Name
주소
32 WIGGINS AVENUE, BEDFORD, MA
Name
직원
288
Name
트위터
Name
다음 수익 날짜
2025-03-12
Name
최신 SEC 제출 서류
Name
ANIK's Discussions on Twitter

ANIK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
10.53 165.64M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
14.60 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.19 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.36 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.37 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.65 20.17B 16.54B -1.64B 749.00M -1.45

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-17 개시 B. Riley Securities Buy
2024-11-01 재확인 Barrington Research Outperform
2023-08-14 업그레이드 Barrington Research Mkt Perform → Outperform
2023-03-07 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-11-09 업그레이드 Barrington Research Mkt Perform → Outperform
2022-10-14 재개 Stephens Equal-Weight
2022-03-09 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-03-09 다운그레이드 Stephens Overweight → Equal-Weight
2021-11-16 개시 Stephens Overweight
2021-07-16 개시 UBS Neutral
2020-12-16 업그레이드 Barrington Research Mkt Perform → Outperform
2020-05-08 다운그레이드 Barrington Research Outperform → Mkt Perform
2020-01-21 업그레이드 Sidoti Neutral → Buy
2020-01-10 업그레이드 First Analysis Sec Outperform → Strong Buy
2019-11-05 개시 BWS Financial Sell
2019-09-24 재확인 Barrington Research Outperform
2019-09-23 다운그레이드 First Analysis Sec Strong Buy → Outperform
2019-07-25 업그레이드 First Analysis Sec Neutral → Strong Buy
2019-02-22 다운그레이드 First Analysis Sec Outperform → Neutral
2019-02-22 다운그레이드 Sidoti Buy → Neutral
2018-07-27 업그레이드 Barrington Research Mkt Perform → Outperform
2018-06-20 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-06-20 다운그레이드 First Analysis Sec Overweight → Equal-Weight
2018-05-04 업그레이드 Barrington Research Mkt Perform → Outperform
2018-02-23 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-01-24 업그레이드 First Analysis Sec Equal-Weight → Overweight
2017-10-27 재확인 Barrington Research Outperform
2016-05-09 업그레이드 Singular Research BUY - Long-Term → Buy
2016-04-27 다운그레이드 Northland Capital Outperform → Market Perform
2016-02-26 재확인 Barrington Research Outperform
모두보기

Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스

pulisher
Jun 15, 2025

Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Cuts Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Bank of America Corp DE Boosts Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Sells 14,006 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Invests $212,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Invests $231,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Public Employees Retirement System of Ohio Invests $137,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ANIK Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Latest: Orthopedics Leader Anika Therapeutics Issues New Employee Stock Options Worth $28,625 - Stock Titan

Jun 05, 2025
pulisher
Jun 05, 2025

Kalkine Biggest NASDAQ Companies Including Anika Therapeutics in Biotechnology Sector - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Sells 12,800 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Boosts Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Long Term Trading Analysis for (ANIK) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Jane Street Group LLC Acquires 3,065 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 31, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Increases Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 29, 2025
pulisher
May 26, 2025

Deutsche Bank AG Lowers Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 26, 2025
pulisher
May 15, 2025

Orthopedic Regenerative Medicine Market Is Booming Worldwide | - openPR.com

May 15, 2025
pulisher
May 14, 2025

Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth - MSN

May 14, 2025
pulisher
May 13, 2025

Anika Therapeutics (ANIK) Sees Target Price Adjustment Amid Futu - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Tower Research Capital LLC TRC Acquires 2,326 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 13, 2025
pulisher
May 13, 2025

Anika Therapeutics (NASDAQ:ANIK) Downgraded by StockNews.com to “Hold” - Defense World

May 13, 2025
pulisher
May 12, 2025

Anika Therapeutics (ANIK) Stock Maintains "Outperform" Rating De - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Viscosupplementation Market: Executive Briefing & Strategic - openPR.com

May 12, 2025
pulisher
May 12, 2025

Company News for May 12, 2025 - Zacks Investment Research

May 12, 2025
pulisher
May 11, 2025

Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 11, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 11, 2025
pulisher
May 10, 2025

Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price - simplywall.st

May 10, 2025
pulisher
May 10, 2025

Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial G - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Dimensional Fund Advisors LP Sells 50,011 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 10, 2025
pulisher
May 10, 2025

Anika: Q1 Earnings Snapshot - News-Times

May 10, 2025
pulisher
May 10, 2025

Anika Reports First Quarter 2025 Financial Results - GlobeNewswire

May 10, 2025
pulisher
May 10, 2025

Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Earnings call transcript: Anika Therapeutics Q1 2025 misses forecasts, shares fall - Investing.com Nigeria

May 10, 2025
pulisher
May 09, 2025

Anika Therapeutics Reports Mixed Q1 2025 Results - TipRanks

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics’ Mixed Earnings Call Reveals Challenges and Growth - TipRanks

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 M - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial Growth - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics (ANIK) Reports Revenue Miss, Highlights Strat - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 Misses Estimate, Revenue of $26.2M Below Expectations - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Anika (ANIK) Revises 2025 Revenue and Adjusted EBITDA Outlook | ANIK Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics Reports 18% Growth in Commercial Channel Revenue for Q1 2025 Despite Overall Revenue Decline - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Buys 2,093 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 09, 2025
pulisher
May 08, 2025

Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result - GuruFocus

May 08, 2025

Anika Therapeutics Inc (ANIK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Anika Therapeutics Inc 주식 (ANIK) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
Nunes Anne
SVP, Chief Operations Officer
Oct 01 '24
Option Exercise
0.00
2,491
0
14,211
$14.44
price up icon 1.09%
$9.18
price up icon 2.80%
$128.04
price up icon 1.87%
$290.91
price up icon 1.14%
drug_manufacturers_specialty_generic RDY
$14.94
price down icon 0.60%
$16.65
price down icon 0.63%
자본화:     |  볼륨(24시간):